When was Adiuvo Diagnostics founded?

Adiuvo Diagnostics was founded in 2015 and raised its 1st funding round 2 years after it was founded.

Where is Adiuvo Diagnostics located?

Adiuvo Diagnostics is headquartered in Nellore, India. It is registered at 1/206 NC BALAIAH NAGAR, NAWABPET, NELLORE, Andhra Pradesh, India, 524002.

Who is the current CEO of Adiuvo Diagnostics?

Geethanjali Radhakrishnan of Adiuvo Diagnostics.

Which legal entities is Adiuvo Diagnostics associated with?

Adiuvo Diagnostics is associated with ADIUVO DIAGNOSTICS PRIVATE LIMITED.

How many employees does Adiuvo Diagnostics have?

As of Aug 31, 2025, the latest employee count at Adiuvo Diagnostics is 23.

Is Adiuvo Diagnostics a funded company?

Adiuvo Diagnostics is a funded company, having raised a total of $2M across 6 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Feb 09, 2017.

How much is Adiuvo Diagnostics worth?

The latest valuation of Adiuvo Diagnostics is $***** as of Feb 15, 2020.

When was the latest funding round of Adiuvo Diagnostics?

Adiuvo Diagnostics' latest funding was a $***** Grant (prize money) round on 2023, with participation from 1 investor.

What is the annual revenue of Adiuvo Diagnostics?

Annual revenue of Adiuvo Diagnostics is less than ₹10 Cr as on Mar 31, 2025

Where does Adiuvo Diagnostics rank among its competitors?

Adiuvo Diagnostics ranks 2nd amongst 10 active competitors, of which 3 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Spectral, which secured $31.7M in Mar, 2026.

Who are the top competitors of Adiuvo Diagnostics?

Adiuvo Diagnostics' top competitors include Spectral, Epocare and Omnidermal. Among them, Spectral secured the most recent funding round in March, 2026.

Adiuvo Diagnostics - 2026 Company Profile, Team, Funding, Competitors & Financials

Adiuvo Diagnostics is a seed company based in Nellore (India), founded in 2015 by Geethanjali Radhakrishnan. It operates as a Provider of digital products to detect skin diseases and infections. Adiuvo Diagnostics has raised $2M in funding from investors like Menterra Venture Advisors, Villgro and Artha Impact, with a current valuation of $*****. The company has 10 active competitors, including 3 funded and 1 that has exited. Its top competitors include companies like Spectral, Epocare and Omnidermal.

Company Details

Provider of digital products to detect skin diseases and infections. The company's flagship product is Illuminate is a wound infection screening device which uses artificial intelligence that provides a label free, non contact gram type bacterial recognition.

Website: www.adiuvodiagnostics.com/
Registered Address: 1/206 NC BALAIAH NAGAR, NAWABPET, NELLORE, Andhra Pradesh, India, 524002

Key Metrics

Founded Year

2015

Location

Nellore, India

Stage

Seed

Total Funding

$2M in 6 rounds

Latest Funding Round

Grant (prize money), 2023, $*****

Post Money Valuation

$***** as on Feb 15, 2020

Investors

Menterra Venture Advisors & 9 more

Ranked

2^nd among 10 active competitors

Annual Revenue

0 - ₹10 Cr as on Mar 31, 2025

Employee Count

23 as on Aug 31, 2025

Similar Companies

Spectral & 8 more

View Adiuvo Diagnostics' full profile

Adiuvo Diagnostics is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ADIUVO DIAGNOSTICS PRIVATE LIMITED CIN: U74120AP2015PTC097966 , India, Active	Dec 29, 2015	0 - ₹10 Cr (As on Mar 31, 2025)	23 (As on Aug 31, 2025)

Adiuvo Diagnostics has raised a total funding of $2M over 6 rounds. Its first funding round was on Feb 09, 2017. Its latest funding round was a Grant (prize money) round on 2023 for $*****. 1 investor participated in its latest round. Adiuvo Diagnostics has 10 institutional investors.

Here is the list of recent funding rounds of Adiuvo Diagnostics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
2023	2673	Grant (prize money)	8439	7557	1299	9874
Dec 23, 2020	4708186	Grant (prize money)	2488323	2918229	8958189	Anthem Biosciences & 1 more
Feb 15, 2020	7367057	Seed	8619252	8742073	Menterra Venture Advisors & 1 more	6001893

Access funding benchmarks and valuations. Sign up today!

View details of Adiuvo Diagnostics's funding rounds and investors

The founders of Adiuvo Diagnostics is Geethanjali Radhakrishnan. Geethanjali Radhakrishnan is the CEO of Adiuvo Diagnostics.

Here are the details of Adiuvo Diagnostics' key team members:

Geethanjali Radhakrishnan: Founder & CEO of Adiuvo Diagnostics. They serve on the board of 1 company.

Adiuvo Diagnostics' Board of Directors

Adiuvo Diagnostics's board has 3 active members. Mukesh Sharma, Geethanjali Radhakrishnan and Vijaya Lakshmi Kummaragunta are part of team.

Here is the list of Adiuvo Diagnostics' board of directors:

Name	Type	Representing	Status	Duration
Geethanjali Radhakrishnan	Team	-	Current	10y 7m
Vijaya Lakshmi Kummaragunta	Team	-	Current	10y 7m
Mukesh Sharma	Investor	Menterra Venture Advisors	Current	7y 4m

View details of Adiuvo Diagnostics's Founder profiles and Board Members

Adiuvo Diagnostics' employee count trend

Adiuvo Diagnostics has 23 employees as of Aug 25. The total employee count is 5.0% more than what it was in Aug 24. Here is Adiuvo Diagnostics's employee count trend over the years:

Employee count trend for Adiuvo Diagnostics

Uncover Adiuvo Diagnostics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Adiuvo Diagnostics include Spectral, Epocare and Omnidermal. Here is the list of Top 10 competitors of Adiuvo Diagnostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Spectral 2009, Dallas (United States), Public	AI-powered tool for medical diagnostics and wound healing predictions	-	Medical Countermeasures, National Science Foundation ... & 2 others	54/100
2nd	Adiuvo Diagnostics 2015, Nellore (India), Seed	Provider of digital products to detect skin diseases and infections	$2M	Villgro, C-CAMP & 8 others	43/100
3rd	Epocare 2016, Mumbai (India), Seed	Provider of a portable handheld imaging device to monitor chronic wounds	$15.4K	SINE, Plugin Alliance & 2 others	33/100
4th	Omnidermal 2017, Parma (Italy), Funding Raised	Developer of an AI enabled wound monitoring device	-	I3P	24/100
5th	Are-Europe Brussels (Belgium), Unfunded	Developer of web server and website management software and tools	-	-	24/100
6th	OxiLight 2015, Toronto (Canada), Seed	Wound imaging solutions for diabetic foot ulcers and peripheral vascular disease	-	Ontario Centre of Innovation, Startupbootcamp	23/100
7th	Auxillium Health 2022, West Allis (United States), Unfunded	AI-powered solutions to healthcare professionals for wound assessment	-	-	19/100
8th	Woundaid 2019, Singapore (Singapore), Unfunded	Provider of an AI-powered wound analysis device for medical applications	-	-	16/100
9th	Decxpert Unfunded	AI-based medical imaging diagnostic software	-	-	16/100
10th	MaxiTracin 2011, Funding Raised	Developer of AI based wound management system for LTHC facilities	-	NYVC	15/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Adiuvo Diagnostics's competitors? Click here to see the top ones

Founders own 41.14%, Funds (largest shareholder) own 48.57% and ESOP Pool own 10.29%. The net worth of Adiuvo Diagnostics's founders is INR 5.76Cr as of Feb 15, 2020.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	41.14%	5.76Cr	9770798	3273836	9259365	6129876
Geethanjali Radhakrishnan	3542905	5147113	1852576	3057259	5959011	3806549
Fund	48.57%	6.8Cr	3116362	4170178	6761141	7058168
Menterra Venture Advisors	4378402	5257598	5256123	9020173	3420173	1611047
Artha Impact	2666151	8943569	9719274	9964537	3121557	2460843
ESOP Pool	10.29%	1.44Cr	5741309	3069554	5097092	2958252
Total	100.00%	14Cr	8809613	9623170	2536590	9473370